Loading clinical trials...
Loading clinical trials...
A Double-blind, Placebo-controlled Phase IIa Study to Evaluate the Efficacy and Safety of AZD7798 in Patients With Moderate to Severe Crohn's Disease
Conditions
Interventions
AZD7798
Placebo
Locations
156
United States
Research Site
Phoenix, Arizona, United States
Research Site
Escondido, California, United States
Research Site
La Jolla, California, United States
Research Site
Victorville, California, United States
Research Site
Hamden, Connecticut, United States
Research Site
Orlando, Florida, United States
Start Date
August 28, 2024
Primary Completion Date
May 1, 2026
Completion Date
May 14, 2027
Last Updated
April 8, 2026
Lead Sponsor
AstraZeneca
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions